Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
Associated with neural tube defects
|
Valproic acid
|
|
Phenytoin: mechanism of action
|
Membrane stabilizer: use-dependent inactivation of Na+ channels
|
|
Fosphenytoin
|
IV; converted to Phenytoin in the body
|
|
Drug with zero-order kinetics and what that means
|
Phenytoin: dose vs. serum amount is not linear. Shoots up at therapeutic range. Easy to OD.
|
|
AEs of Fosphenytoin
|
Bradycardia, hypotension.
|
|
Nystagmus is seen at therapeutic levels in which drug?
|
Phenytoin
|
|
Dose-dependent AEs of Phenytoin
|
Sedation, ataxia, nausea, vomiting
|
|
Chronic use AEs of Phenytoin
|
Gingival hyperplasia, hirsutism
|
|
Mechanism of action of Carbamazepine
|
Membrane stabilizer: use-dependent inactivation of Na+ channels
|
|
Route of elimination of Carbamazepine
|
Autoinduction of hepatic enzymes. Blood levels will drop within the first month of use, so dose will need to be increased.
|
|
Autoinduction
|
Carbamazepine
|
|
Chronic AEs of Carbamazepine
|
SIADH
|
|
Idiosyncratic AEs of Carbamazepine
|
Agranulocytosis, aplastic anemia, hepatic failure, allergic skin rash
|
|
Barbituates: names
|
Phenobarbital, Primidone
|
|
Mechanism of action of Barbituates
|
Augments GABA
|
|
Mechanism of action of valproic acid
|
Augments GABA. Also suppresses Ca T-channel currents, so can be used to treat absence seizures.
|
|
Dose-dependent AEs of valproic acid
|
Nausea, tremor
|
|
Idiosyncratic AEs of valproic acid
|
Alopecia, hepatic failure in very young children, neural tube defects.
|
|
Enzyme inducers (reduce the levels of other meds)
|
Phenytoin, Barbituates, Carbamazepine
|
|
Enzyme inhibitors (increase the levels of other meds)
|
Valproic acid
|
|
Benzodiazepines: names
|
Clonazepam, Diazepam, Lorazepam
|
|
Clonazepam: use
|
Oral only. Used for myoclonic seizures.
|
|
Diazepam: use
|
IV, for status epilepticus
|
|
Lorazepam: use
|
IV, for status epilepticus
|
|
Mechanism of action of Benzodiazepines
|
Augments GABA
|
|
Drug of choice for absence seizures
|
Ethosuximide
|
|
Mechanism of action of Ethosuximide
|
Blocks Ca T-channels. Inhibits the thalamocortical circuit underlying the 3/sec rhythm.
|
|
Drug that is excreted unchanged by the kidneys
|
Gabapentin
|
|
Dose-dependent AEs of Lamotrigine
|
Sedation, ataxia, nausea, RASH (especially when given too much too quickly)
|
|
Used for migraine prophylaxis
|
Topiramate
|
|
AEs of Topiramate
|
Cognitive impairment, non-ion-gap metabolic acidosis, kidney stones
|
|
Mechanism of action of Tiagabine
|
Selective inhibitor of GABA reuptake
|
|
Uses of Levetiracetam
|
status epilepticus (IV)
|
|
Drug interactions of Levetiracetam
|
NONE
|
|
New drug that can be used as a monotherapy
|
Zonisamide
|
|
Dose-dependent AEs of Zonisamide
|
Weight loss, kidney stones, cognitive impairment, metabolic acidosis
|
|
Uptake of Oxcarbazepine
|
Rapid and complete absorption. Cytosolic metabolism to active 10-monohydroxy metabolite. No epoxide formation-->lesser incidence of skin rash and blood dyscrasias.
|
|
Indications for Pregabalin
|
Post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia.
|
|
Side effects of Lacosamide
|
Syncope; beware of use in cardiac patients.
|